ID   HCN2_RAT                Reviewed;         863 AA.
AC   Q9JKA9; F1LRY7; Q6BCT5; Q9QZW6;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   24-JUL-2024, sequence version 4.
DT   24-JUL-2024, entry version 165.
DE   RecName: Full=Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2;
GN   Name=Hcn2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=15265006; DOI=10.1111/j.1356-9597.2004.00752.x;
RA   Kimura K., Kitano J., Nakajima Y., Nakanishi S.;
RT   "Hyperpolarization-activated, cyclic nucleotide-gated HCN2 cation channel
RT   forms a protein assembly with multiple neuronal scaffold proteins in
RT   distinct modes of protein-protein interaction.";
RL   Genes Cells 9:631-640(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 30-863, AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=11000485; DOI=10.1016/s0169-328x(00)00155-8;
RA   Monteggia L.M., Eisch A.J., Tang M.D., Kaczmarek L.K., Nestler E.J.;
RT   "Cloning and localization of the hyperpolarization-activated cyclic
RT   nucleotide-gated channel family in rat brain.";
RL   Brain Res. Mol. Brain Res. 81:129-139(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 184-350.
RC   TISSUE=Heart;
RX   PubMed=10400919; DOI=10.1161/01.res.85.1.e1;
RA   Shi W., Wymore R., Yu H., Wu J., Wymore R.T., Pan Z., Robinson R.B.,
RA   Dixon J.E., McKinnon D., Cohen I.S.;
RT   "Distribution and prevalence of hyperpolarization-activated cation channel
RT   (HCN) mRNA expression in cardiac tissues.";
RL   Circ. Res. 85:1-6(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [5]
RP   FUNCTION, TRANSPORTER ACTIVITY, AND SUBCELLULAR LOCATION.
RC   TISSUE=Kidney;
RX   PubMed=21796099; DOI=10.1038/ki.2011.230;
RA   Carrisoza-Gaytan R., Rangel C., Salvador C., Saldana-Meyer R., Escalona C.,
RA   Satlin L.M., Liu W., Zavilowitz B., Trujillo J., Bobadilla N.A.,
RA   Escobar L.I.;
RT   "The hyperpolarization-activated cyclic nucleotide-gated HCN2 channel
RT   transports ammonium in the distal nephron.";
RL   Kidney Int. 80:832-840(2011).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-119; SER-134; SER-726;
RP   SER-750 AND SER-842, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Hyperpolarization-activated ion channel exhibiting weak
CC       selectivity for potassium over sodium ions (PubMed:21796099).
CC       Contributes to the native pacemaker currents in heart (If) and in
CC       neurons (Ih). Can also transport ammonium in the distal nephron
CC       (PubMed:21796099). Involved in the initiation of neuropathic pain in
CC       sensory neurons. Produces a large instantaneous current
CC       (PubMed:21796099). {ECO:0000269|PubMed:21796099}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Na(+)(in) = Na(+)(out); Xref=Rhea:RHEA:34963,
CC         ChEBI:CHEBI:29101; Evidence={ECO:0000269|PubMed:21796099};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=K(+)(in) = K(+)(out); Xref=Rhea:RHEA:29463, ChEBI:CHEBI:29103;
CC         Evidence={ECO:0000269|PubMed:21796099};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=NH4(+)(in) = NH4(+)(out); Xref=Rhea:RHEA:28747,
CC         ChEBI:CHEBI:28938; Evidence={ECO:0000269|PubMed:21796099};
CC   -!- ACTIVITY REGULATION: Activated by cAMP, and at 10-100 times higher
CC       concentrations, also by cGMP. cAMP binding causes a conformation change
CC       that leads to the assembly of an active tetramer and channel opening
CC       (PubMed:21796099). In the absence of cAMP, the C-terminal region is
CC       thought to exert a tonic inhibition on the pore when HCN2 is in a non-
CC       tetrameric form (By similarity). Channel activity is modulated by
CC       intracellular chloride ions and pH; acidic pH shifts the activation to
CC       more negative voltages (By similarity). Phosphatidylinositol-
CC       4,5- bisphosphate (PIP(2)) acts as a ligand that allosterically opens
CC       HCN2 by shifting voltage-dependent channel activation toward
CC       depolarized potentials (By similarity). Inhibited by extracellular
CC       cesium ions (By similarity). {ECO:0000250|UniProtKB:O88703,
CC       ECO:0000250|UniProtKB:Q9UL51, ECO:0000269|PubMed:21796099}.
CC   -!- SUBUNIT: Homotetramer (By similarity). The channel is composed of a
CC       homo- or heterotetrameric complex of pore-forming subunits (By
CC       similarity). Heterotetramer with HCN1 (By similarity). Forms an
CC       obligate 4:4 complex with accessory subunit PEX5L. Interacts with KCNE2
CC       (By similarity). {ECO:0000250|UniProtKB:O88703,
CC       ECO:0000250|UniProtKB:Q9UL51}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:21796099};
CC       Multi-pass membrane protein {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in neonatal and adult ventricle
CC       and in brain. Highly expressed in the pyramidal layer in hippocampus,
CC       in anterior dorsal nucleus in thalamus, in the mammillary nucleus in
CC       hypothalamus, in red nucleus, in trigeminal mesencephalic, spinal and
CC       principal nuclei, in cochlear and trapezoid nuclei and in the dorsal
CC       tegemental nucleus. {ECO:0000269|PubMed:11000485}.
CC   -!- DOMAIN: The segment S4 is the voltage-sensor and is characterized by a
CC       series of positively charged amino acids at every third position. Thee
CC       ion-conducting pore region is between segment S5 and S6.
CC       {ECO:0000250|UniProtKB:O60741}.
CC   -!- DOMAIN: The cytosolic C-terminal domain contains the cyclic nucleotide-
CC       binding domain (CNBD), which mediates modulation by cyclic nucleotides.
CC       {ECO:0000250|UniProtKB:O88703}.
CC   -!- PTM: Phosphorylation at Ser-641 by PRKG2 shifts the voltage-dependence
CC       to more negative voltages, hence counteracting the stimulatory effect
CC       of cGMP on gating. {ECO:0000250|UniProtKB:O88703}.
CC   -!- PTM: N-glycosylated; required for cell surface trafficking of HCN2.
CC       {ECO:0000250|UniProtKB:O88703}.
CC   -!- PTM: S-palmitoylated. {ECO:0000250|UniProtKB:Q9UL51}.
CC   -!- SIMILARITY: Belongs to the potassium channel HCN family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB164197; BAD32628.1; -; mRNA.
DR   EMBL; AF247451; AAF62174.1; -; mRNA.
DR   EMBL; AF155164; AAF01491.1; -; mRNA.
DR   EMBL; AC097878; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR07073281; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_446136.1; NM_053684.1.
DR   AlphaFoldDB; Q9JKA9; -.
DR   BMRB; Q9JKA9; -.
DR   SMR; Q9JKA9; -.
DR   BioGRID; 250321; 1.
DR   STRING; 10116.ENSRNOP00000011837; -.
DR   GlyCosmos; Q9JKA9; 1 site, No reported glycans.
DR   GlyGen; Q9JKA9; 1 site.
DR   iPTMnet; Q9JKA9; -.
DR   PhosphoSitePlus; Q9JKA9; -.
DR   PaxDb; 10116-ENSRNOP00000011837; -.
DR   ABCD; Q9JKA9; 1 sequenced antibody.
DR   Ensembl; ENSRNOT00000011837.7; ENSRNOP00000011837.7; ENSRNOG00000008831.7.
DR   Ensembl; ENSRNOT00055053819; ENSRNOP00055044538; ENSRNOG00055031041.
DR   Ensembl; ENSRNOT00060046853; ENSRNOP00060038962; ENSRNOG00060027027.
DR   Ensembl; ENSRNOT00065034581; ENSRNOP00065027726; ENSRNOG00065020456.
DR   GeneID; 114244; -.
DR   KEGG; rno:114244; -.
DR   UCSC; RGD:620689; rat.
DR   AGR; RGD:620689; -.
DR   CTD; 610; -.
DR   RGD; 620689; Hcn2.
DR   VEuPathDB; HostDB:ENSRNOG00000008831; -.
DR   eggNOG; KOG0498; Eukaryota.
DR   GeneTree; ENSGT00940000156523; -.
DR   HOGENOM; CLU_005746_15_1_1; -.
DR   InParanoid; Q9JKA9; -.
DR   OMA; GGIGMIC; -.
DR   OrthoDB; 74296at2759; -.
DR   PhylomeDB; Q9JKA9; -.
DR   TreeFam; TF318250; -.
DR   Reactome; R-RNO-1296061; HCN channels.
DR   PRO; PR:Q9JKA9; -.
DR   Proteomes; UP000002494; Chromosome 7.
DR   Bgee; ENSRNOG00000008831; Expressed in frontal cortex and 15 other cell types or tissues.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0030425; C:dendrite; IBA:GO_Central.
DR   GO; GO:0032590; C:dendrite membrane; IDA:RGD.
DR   GO; GO:0043198; C:dendritic shaft; IDA:RGD.
DR   GO; GO:0098855; C:HCN channel complex; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0036477; C:somatodendritic compartment; IDA:RGD.
DR   GO; GO:0030552; F:cAMP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0005222; F:intracellularly cAMP-activated cation channel activity; ISS:UniProtKB.
DR   GO; GO:0060090; F:molecular adaptor activity; IDA:RGD.
DR   GO; GO:0030165; F:PDZ domain binding; IPI:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; ISS:UniProtKB.
DR   GO; GO:0005248; F:voltage-gated sodium channel activity; ISO:RGD.
DR   GO; GO:0072488; P:ammonium transmembrane transport; IDA:UniProtKB.
DR   GO; GO:1904045; P:cellular response to aldosterone; IEP:RGD.
DR   GO; GO:0071320; P:cellular response to cAMP; ISS:UniProtKB.
DR   GO; GO:0071321; P:cellular response to cGMP; ISO:RGD.
DR   GO; GO:1990573; P:potassium ion import across plasma membrane; ISO:RGD.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0003254; P:regulation of membrane depolarization; IBA:GO_Central.
DR   GO; GO:0042391; P:regulation of membrane potential; ISO:RGD.
DR   GO; GO:0009725; P:response to hormone; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0098719; P:sodium ion import across plasma membrane; IDA:UniProtKB.
DR   GO; GO:0035725; P:sodium ion transmembrane transport; ISO:RGD.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 1.10.287.70; -; 1.
DR   Gene3D; 1.10.287.630; Helix hairpin bin; 1.
DR   Gene3D; 2.60.120.10; Jelly Rolls; 1.
DR   InterPro; IPR018488; cNMP-bd_CS.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR018490; cNMP-bd_dom_sf.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR013621; Ion_trans_N.
DR   InterPro; IPR051413; K/Na_HCN_channel.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   PANTHER; PTHR45689; I[[H]] CHANNEL, ISOFORM E; 1.
DR   PANTHER; PTHR45689:SF11; POTASSIUM_SODIUM HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED CHANNEL 2; 1.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF08412; Ion_trans_N; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; cAMP-binding domain-like; 1.
DR   SUPFAM; SSF81324; Voltage-gated potassium channels; 1.
DR   PROSITE; PS00888; CNMP_BINDING_1; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   1: Evidence at protein level;
KW   Ammonia transport; cAMP; cAMP-binding; Cell membrane; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Lipoprotein;
KW   Membrane; Methylation; Nucleotide-binding; Palmitate; Phosphoprotein;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Sodium; Sodium channel; Sodium transport; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN           1..863
FT                   /note="Potassium/sodium hyperpolarization-activated cyclic
FT                   nucleotide-gated channel 2"
FT                   /id="PRO_0000054113"
FT   TOPO_DOM        1..188
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        189..209
FT                   /note="Helical; Name=Segment S1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        210..213
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        214..234
FT                   /note="Helical; Name=Segment S2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        235..261
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        262..282
FT                   /note="Helical; Name=Segment S3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        283..290
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        291..311
FT                   /note="Helical; Voltage-sensor; Name=Segment S4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        312..342
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        343..363
FT                   /note="Helical; Name=Segment S5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        364..386
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   INTRAMEM        387..408
FT                   /note="Pore-forming; Name=Segment H5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        409..413
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        414..434
FT                   /note="Helical; Name=Segment S6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        435..863
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          1..131
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          131..182
FT                   /note="Involved in subunit assembly"
FT                   /evidence="ECO:0000250"
FT   REGION          730..863
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        15..51
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        732..759
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        811..825
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         581
FT                   /ligand="3',5'-cyclic AMP"
FT                   /ligand_id="ChEBI:CHEBI:58165"
FT                   /evidence="ECO:0000250|UniProtKB:O88703"
FT   BINDING         582
FT                   /ligand="3',5'-cyclic AMP"
FT                   /ligand_id="ChEBI:CHEBI:58165"
FT                   /evidence="ECO:0000250|UniProtKB:O88703"
FT   BINDING         584
FT                   /ligand="3',5'-cyclic AMP"
FT                   /ligand_id="ChEBI:CHEBI:58165"
FT                   /evidence="ECO:0000250|UniProtKB:O88703"
FT   BINDING         591
FT                   /ligand="3',5'-cyclic AMP"
FT                   /ligand_id="ChEBI:CHEBI:58165"
FT                   /evidence="ECO:0000250|UniProtKB:O88703"
FT   BINDING         592
FT                   /ligand="3',5'-cyclic AMP"
FT                   /ligand_id="ChEBI:CHEBI:58165"
FT                   /evidence="ECO:0000250|UniProtKB:O88703"
FT   BINDING         632
FT                   /ligand="3',5'-cyclic AMP"
FT                   /ligand_id="ChEBI:CHEBI:58165"
FT                   /evidence="ECO:0000250|UniProtKB:O88703"
FT   MOD_RES         119
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         134
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         641
FT                   /note="Phosphoserine; by PKG/PRKG2"
FT                   /evidence="ECO:0000250|UniProtKB:O88703"
FT   MOD_RES         726
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         728
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:O88703"
FT   MOD_RES         743
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O88703"
FT   MOD_RES         750
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         757
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O88703"
FT   MOD_RES         840
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O88703"
FT   MOD_RES         842
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         847
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O88703"
FT   CARBOHYD        380
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000250|UniProtKB:O88703"
FT   CONFLICT        686
FT                   /note="L -> F (in Ref. 2; AAF62174)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        693
FT                   /note="P -> R (in Ref. 2; AAF62174)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        696
FT                   /note="T -> R (in Ref. 2; AAF62174)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   863 AA;  94710 MW;  B261595E4533F4BA CRC64;
     MDARGGGGRP GDSPGATPAP GPPPPPPPPA PPQPQPPPAP PPNPTTPSHP ESADEPGPRS
     RLCSRDSSCT PGAAKGGANG ECGRGEPQCS PEGPARGPKV SFSCRGAASG PAAAEEAGSE
     EAGPAGEPRG SQASFLQRQF GALLQPGVNK FSLRMFGSQK AVEREQERVK SAGAWIIHPY
     SDFRFYWDFT MLLFMVGNLI IIPVGITFFK DETTAPWIVF NVVSDTFFLM DLVLNFRTGI
     VIEDNTEIIL DPEKIKKKYL RTWFVVDFVS SIPVDYIFLI VEKGIDSEVY KTARALRIVR
     FTKILSLLRL LRLSRLIRYI HQWEEIFHMT YDLASAVMRI CNLISMMLLL CHWDGCLQFL
     VPMLQDFPSD CWVSINNMVN HSWSELYSFA LFKAMSHMLC IGYGRQAPES MTDIWLTMLS
     MIVGATCYAM FIGHATALIQ SLDSSRRQYQ EKYKQVEQYM SFHKLPADFR QKIHDYYEHR
     YQGKMFDEDS ILGELNGPLR EEIVNFNCRK LVASMPLFAN ADPNFVTAML TKLKFEVFQP
     GDYIIREGTI GKKMYFIQHG VVSVLTKGNK EMKLSDGSYF GEICLLTRGR RTASVRADTY
     CRLYSLSVDN FNEVLEEYPM MRRAFETVAI DRLDRIGKKN SILLHKVQHD LSSGVFNNQE
     NAIIQEIVKY DREMVQQAEL GQRVGLFPPP PPPQVTSAIA TLQQAVAMSF CPQVARPLVG
     PLALGSPRLV RRAPPGPLPP AASPGPPAAS PPAAPSSPRA PRTSPYGVPG SPATRVGPAL
     PARRLSRASR PLSASQPSLP HGAPAPSPAA SARPASSSTP RLGPAPTTRT AAPSPDRRDS
     ASPGAASGLD PLDSARSRLS SNL
//
